March 23, 2025 - 10:21

Today, the Obesity Action Coalition (OAC) and The Obesity Society (TOS) have taken a significant step by sending a letter to the U.S. Food and Drug Administration (FDA). This letter, supported by over 20 prominent organizations and providers from various sectors of healthcare, emphasizes the urgent need for the FDA to implement and enforce federal regulations concerning compounding practices.
The call to action comes in the wake of recent shortages of GLP-1 medications, which are crucial for the treatment of obesity and related conditions. These shortages have raised serious concerns about patient access to essential therapies. The coalition argues that without stricter oversight and regulation of compounded medications, patients may face continued disruptions in their treatment options.
Healthcare leaders are advocating for a timely response from the FDA to ensure that patients receive the medications they need without interruption, highlighting the importance of regulatory frameworks in safeguarding public health.
April 21, 2026 - 02:20
Christina Applegate addresses health concerns after reported hospitalizationActress Christina Applegate has returned to social media with a heartfelt message of gratitude and resilience, directly addressing her ongoing health journey. The `Dead to Me` star, who has been...
April 20, 2026 - 12:23
He started pickleball as a hobby — now, at 82, it's his second careerAt 82 years young, Robert Warden has discovered an unexpected second wind, turning a casual hobby into a vibrant new chapter. His journey began in retirement, not with a grand plan, but from a...
April 19, 2026 - 18:17
Trump admin seeks health-care price transparencyA new push for price transparency within federal employee health plans is drawing praise from taxpayer advocates and criticism from healthcare industry leaders. The initiative, championed by the...
April 19, 2026 - 10:47
Pioneering Genetic Researchers Awarded $3 Million for Sickle Cell Cure FoundationDr. Swee Lay Thein and Dr. Stuart Orkin have been honored with the prestigious $3 million Breakthrough Prize in Life Sciences. The award recognizes their decades of foundational research that...